UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 311

Sortiert nach

Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration

Archives of Dermatological Research, 2020-10, Vol.312 (8), p.581-586

2020

Volltextzugriff (PDF)

Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway

Biochemical and biophysical research communications, 2023-06, Vol.659, p.10-19

2023

Volltextzugriff (PDF)

Synthetic derivatives of the antifungal drug ciclopirox are active against herpes simplex virus 2

European journal of medicinal chemistry, 2022-08, Vol.238, p.114443-114443, Article 114443

2022

Volltextzugriff (PDF)

Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly

Nature communications, 2019-05, Vol.10 (1), p.2184-14, Article 2184

2019

Volltextzugriff (PDF)

Reposition of the Fungicide Ciclopirox for Cancer Treatment

Recent patents on anti-cancer drug discovery, 2021-01, Vol.16 (2), p.122

2021

Volltextzugriff (PDF)

Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses

Journal of inorganic biochemistry, 2024-11, Vol.260, p.112696, Article 112696

2024

Volltextzugriff (PDF)

Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation

Mycoses, 2024-03, Vol.67 (3), p.e13710-n/a

2024

Volltextzugriff (PDF)

Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

European journal of pharmacology, 2024-03, Vol.967, p.176369-176369, Article 176369

2024

Volltextzugriff (PDF)

Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine

AAPS PharmSciTech, 2020-10, Vol.21 (7), p.283, Article 283

2020

Volltextzugriff (PDF)

Onychomycosis: Treatment and prevention of recurrence

Journal of the American Academy of Dermatology, 2019-04, Vol.80 (4), p.853

2019

Volltextzugriff (PDF)

Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice

Antiviral research, 2018-08, Vol.156, p.102-106

2018

Volltextzugriff (PDF)

Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells

Cell communication and signaling, 2022-03, Vol.20 (1), p.37-37, Article 37

2022

Volltextzugriff (PDF)

A density functional theory study on the potential application of Ni and Co doped ZnO nanosheets as a carrier for ciclopirox anticancer drug

Computer methods in biomechanics and biomedical engineering, 2024-05, Vol.27 (6), p.765-774

2024

Volltextzugriff (PDF)

Visualisation of penetration of topical antifungal drug substances through mycosis‐infected nails by matrix‐assisted laser desorption ionisation mass spectrometry imaging

Mycoses, 2020-08, Vol.63 (8), p.869-875

2020

Volltextzugriff (PDF)

A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study

PloS one, 2023-05, Vol.18 (5), p.e0285941-e0285941

2023

Volltextzugriff (PDF)

A DFT study of Se-decorated B12N12 nanocluster as a possible drug delivery system for ciclopirox

Computational and theoretical chemistry, 2021-07, Vol.1201, p.113246, Article 113246

2021

Volltextzugriff (PDF)

Onychomycosis in children - review on treatment and management strategies

The Journal of dermatological treatment, 2022-05, Vol.33 (3), p.1213-1224

2022

Volltextzugriff (PDF)

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

Frontiers in microbiology, 2015-04, Vol.6, p.282-282

2015

Volltextzugriff (PDF)

Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Volltextzugriff (PDF)

Effects of the antifungal agent ciclopirox in HPV‐positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis

International journal of cancer, 2020-01, Vol.146 (2), p.461-474

2020

Volltextzugriff (PDF)

Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model

MicrobiologyOpen (Weinheim), 2022-02, Vol.11 (1), p.e1257-n/a

2022

Volltextzugriff (PDF)

Studying Ga and Ge-doped AlP nanotube as a drug carrier for ciclopirox anticancer drug using DFT

Computational and theoretical chemistry, 2023-03, Vol.1221, p.114025, Article 114025

2023

Volltextzugriff (PDF)

Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway

Immunopharmacology and immunotoxicology, 2023-12, Vol.45 (6), p.701-708

2023

Volltextzugriff (PDF)

Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: In vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits

International journal of pharmaceutics, 2021-01, Vol.592, p.120086, Article 120086

2021

Volltextzugriff (PDF)

Ciclopirox olamine promotes the angiogenic response of endothelial cells and mesenchymal stem cells

Clinical hemorheology and microcirculation, 2019-01, Vol.73 (2), p.317

2019

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(240)
Life Sciences & Biomedicine
(219)
Ciclopirox
(205)
Humans
(149)
Pharmacology & Pharmacy
(81)
Ciclopirox Olamine
(75)
Onychomycosis
(69)
Dermatology
(68)
Antifungal Agents - Therapeutic Use
(64)
Biological And Medical Sciences
(62)
Medical Sciences
(56)
Animals
(52)
Female
(52)
Pyridones - Pharmacology
(51)
Onychomycosis - Drug Therapy
(49)
Antifungal Agents - Pharmacology
(48)
Administration, Topical
(47)
Antifungal Agents
(47)
Male
(47)
Pyridones - Therapeutic Use
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration

Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway

Synthetic derivatives of the antifungal drug ciclopirox are active against herpes simplex virus 2

Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly

Reposition of the Fungicide Ciclopirox for Cancer Treatment

Ciclopirox platinum(IV) conjugates suppress tumors by promoting mitophagy and provoking immune responses

Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation

Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

Formulation and Evaluation of Novel Hybridized Nanovesicles for Enhancing Buccal Delivery of Ciclopirox Olamine

Onychomycosis: Treatment and prevention of recurrence

Antifungal drug ciclopirox olamine reduces HSV-1 replication and disease in mice

Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells

A density functional theory study on the potential application of Ni and Co doped ZnO nanosheets as a carrier for ciclopirox anticancer drug

Visualisation of penetration of topical antifungal drug substances through mycosis‐infected nails by matrix‐assisted laser desorption ionisation mass spectrometry imaging

A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study

A DFT study of Se-decorated B12N12 nanocluster as a possible drug delivery system for ciclopirox

Onychomycosis in children - review on treatment and management strategies

Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections

Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance

Effects of the antifungal agent ciclopirox in HPV‐positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis

Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model

Studying Ga and Ge-doped AlP nanotube as a drug carrier for ciclopirox anticancer drug using DFT

Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway

Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: In vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits

Ciclopirox olamine promotes the angiogenic response of endothelial cells and mesenchymal stem cells

Suchergebnisse filtern